Boothbay Fund Management, LLC Teva Pharmaceutical Industries LTD Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $813,740 - $1.15 Million	110,263 Added 120.44%	201,811 $1.52 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $92,621 - $118,652	12,636 Added 16.01%	91,548 $860,000
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $623,404 - $804,113	78,912 New	78,912 $632,000
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $233,043 - $376,544	-28,700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $192,003 - $386,015	28,700 New	28,700 $258,000
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $407,667 - $669,249	-62,430 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $384,568 - $599,328	62,430 New	62,430 $430,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.